| 國立臺灣大學 |
2008-02 |
Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians
|
Lin, YH; Hung, CS; Tseng, WY; Lee, RK; Wang, YC; Lin, MS; Yeh, MH; Chao, CL; Ho, YL; Jeng, JS; Yip, PK; Kao, HL. |
| 臺大學術典藏 |
2020-03-03T03:46:02Z |
Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: The first case series in Asians
|
Lee R.-K.; Wang Y.-C.; Lin M.-S.; Yeh M.-H.; Chao C.-L.; Ho Y.-L.; JIANN-SHING JENG; Yip P.-K.; Kao H.-L.; Lin Y.-H.; Hung C.-S.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2020-12-18T05:21:11Z |
Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: The first case series in Asians
|
Lee R.-K.; Tseng W.-Y.I.; Hung C.-S.; YEN-HUNG LIN; Wang Y.-C.; Lin M.-S.; Yeh M.-H.; Chao C.-L.; Ho Y.-L.; Jeng J.-S.; Yip P.-K.; Kao H.-L. |
| 臺大學術典藏 |
2021-08-24T06:15:04Z |
Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: The first case series in Asians
|
Anonymous |
| 中國醫藥大學 |
2008-03 |
Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians.
|
林彥宏(Yen-Hung Lin); 洪啟盛(Chi-Sheng Hung); (Wen-Yi Issac Tseng,); 李任光(Ren-Kwan Lee); 王宇澄(Yu-Chen Wang); Mao-Shin Lin(林茂欣); (Mei-Hsing Yeh); 趙嘉倫(Chia-Lun Chao); 何奕倫(Yi-Lwun Ho); (Jiann-Shing Jeng); (Ping-Keung Yip); 高憲立(Hsien-Li Kao)* |
| 國立臺灣大學 |
2008 |
Safety and Feasibility of Drug-Eluting Stent Implantation in Vertebral Artery Stenosis - First Asian Case Series
|
林彥宏; 洪啟盛; 曾文毅; 李任光; 王堯弘; 趙嘉倫; 何奕倫; 鄭建興; 葉炳强; 高憲立; LIN, YEN-HUNG; HUNG, CHI-SHENG; TSENG, WEN-YIH; LEE, REN-KWAN; WANG, YAO-HONG; CHAO, CHIA-LUN; HO, YI-LWUN; JENG, JIANN-SHING; YIP, PING-KEUNG; KAO, HSIEN-LI |
| 亞洲大學 |
2017 |
Safety and Health Management of Open Pit Excavation
|
Lin, Cheng-Wei |
| 輔英科技大學 |
2008-02-18 |
SAFETY AND HEALTH OF STAFF IN OPERATING THEATERS
|
石建璋 |
| 中華大學 |
2005 |
Safety and health performance measurement system for a wafer fab
|
李欣怡; Lee, Amy Hsin-I |
| 國立臺灣大學 |
2006 |
Safety and Hemostatic Effect of Recombinant Activated Factor Vii in Cirrhotic Patients Undergoing Partial Hepatectomy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
|
邵永孚; 楊甲梅; 周嘉揚; 李伯皇; SHAO, YONG-FU; YANG, JIA-MEI; CHAU, GAY-YANG; LEE, PO-HUANG |
| 國立臺灣大學 |
2006-02 |
Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial
|
Shao, YF; Yang, JM; Chau, GY; Sirivatanauksorn, Y; Zhong, SX; Erhardtsen, E; Nivatvongs, S; Lee, PH |
| 臺大學術典藏 |
2018-09-10T05:44:51Z |
Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: A multicenter, randomized, double-blind, placebo-controlled trial
|
Shao, Y.-F. and Yang, J.-M. and Chau, G.-Y. and Sirivatanauksorn, Y. and Zhong, S.-X. and Erhardtsen, E. and Nivatvongs, S. and Lee, P.-H.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:20:16Z |
Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: A multicenter, randomized, double-blind, placebo-controlled trial
|
Shao Y.-F.; Yang J.-M.; Chau G.-Y.; Sirivatanauksorn Y.; Zhong S.-X.; Erhardtsen E.; Nivatvongs S.; PO-HUANG LEE |
| 國立臺灣大學 |
1993 |
Safety and Immunogenecity of Hepatitis a Vaccine in Healthy Children
|
Horng, Y. C.; Chang, M. H.; Lee, C. Y.; Safary, A.; Andre, F. E.; 陳定信; Horng, Y. C.; Chang, M. H.; Lee, C. Y.; Safary, A.; Andre, F. E.; Chen, Ding-Shinn |
| 國立臺灣大學 |
2006-05 |
Safety and immunogenecity of heptavalent pneumococcal conjugate vaccine booster in Taiwanese toddlers.
|
Shao, PL; Lu, CY; Chang, LY; Huang, FY; Lee, CY; Hsueh, PR; Huang, LM |
| 國立臺灣大學 |
2004 |
Safety and immunogenecity of heptavalent pneumococcal conjugate vaccine in Taiwanese infants
|
Shao, PL; Lu, Chun-Yi; Chang, LY |
| 臺大學術典藏 |
2018-09-10T06:41:17Z |
Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine
|
Yeh, S.-J.;Huang, L.-M.;Chen, J.-M.;Lee, P.-I.;Chang, L.-Y.;Lin, Y.-J.;Chiu, H.-H.;Lee, C.-Y.; LI-MIN HUANG |
| 臺大學術典藏 |
2020-12-15T07:42:44Z |
Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine
|
Yeh S.-J.;Huang L.-M.;Chen J.-M.;Lee P.-I.;Luan-Yin Chang;Lin Y.-J.;Chiu H.-H.;Lee C.-Y.; Yeh S.-J.; Huang L.-M.; Chen J.-M.; Lee P.-I.; LUAN-YIN CHANG; Lin Y.-J.; Chiu H.-H.; Lee C.-Y. |
| 臺大學術典藏 |
2021-05-13T07:16:09Z |
Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine
|
Yeh S.-J.; Huang L.-M.; JONG-MIN CHEN; Lee P.-I.; Chang L.-Y.; Lin Y.-J.; Chiu H.-H.; Lee C.-Y. |
| 臺大學術典藏 |
2021-06-24T07:20:05Z |
Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine
|
Yeh S.-J.; LI-MIN HUANG; Chen J.-M.; Lee P.-I.; Chang L.-Y.; Lin Y.-J.; Chiu H.-H.; Lee C.-Y. |
| 臺大學術典藏 |
2021-01-07T06:09:23Z |
Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine
|
Yeh S.-J.;Huang L.-M.;Chen J.-M.;Ping-Ing Lee;Chang L.-Y.;Lin Y.-J.;Chiu H.-H.;Lee C.-Y.; Yeh S.-J.; Huang L.-M.; Chen J.-M.; PING-ING LEE; Chang L.-Y.; Lin Y.-J.; Chiu H.-H.; Lee C.-Y. |
| 國立臺灣大學 |
1997 |
Safety and Immunogenicity of a Conjugated Hemophilus Influenzae Type B Polysaccharide-Neisseria Meningitidis Outer Membrane Protein Vaccine
|
黃立民; 陳中明; 李秉穎; 張鑾英; 林逸甄; 丘秀慧; 李慶雲; HUANG, LI-MIN; CHEN, CHUNG-MING; LEE, PING-ING; CHANG, LUAN-YIN; LIN, YI-JANE; CHIU, HSIU-HUI; LEE, CHIN-YUN |
| 國立臺灣大學 |
1997-12 |
Safety and immunogenicity of a conjugated Hemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein vaccine.
|
Yeh, SJ; Huang, LM; Chen, JM; Lee, PI; Chang, LY; Lin, YJ; Chiu, HH; Lee, CY |
| 國立臺灣大學 |
2003 |
Safety and Immunogenicity of a Diphtheria, Tetanus, and Acellular Pertussis-Inactivated Poliovirus Vaccine/Haemophilus Influenzae Type B Combination Vaccine Administered to Taiwanese Infants At
|
林奏延; 張鑾英; 黃玉成; LIN, TZOU-YIEN; CHANG, LUAN-YIN; HUANG, YHU-CHERING |
| 國立臺灣大學 |
2003 |
Safety and immunogenicity of a Diphtheria, Tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus Influenzae type B combination Vaccine administered to Taiwanese infants at 2, 4 and 6 months of age
|
Lin, TY; Wang, YH; Chang, LY; Chiu, CH; Huang, YC; Tang, H; Bock, HL |
| 臺大學術典藏 |
2020-12-15T07:42:38Z |
Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type b combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age
|
Lin T.-Y.;Wang Y.-H.;Luan-Yin Chang;Chiu C.-H.;Huang Y.-C.;Tang H.;Bock H.L.; Lin T.-Y.; Wang Y.-H.; LUAN-YIN CHANG; Chiu C.-H.; Huang Y.-C.; Tang H.; Bock H.L. |
| 臺大學術典藏 |
2018-09-10T18:05:55Z |
Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
|
Chiu, N.-C. ;Huang, L.-M. ; Willemsen, A. ; Bhusal, C. ; Arora, A.K. ; Mojares, Z.R. ; Toneatto, D.; LI-MIN HUANG |
| 臺大學術典藏 |
2021-06-24T07:16:17Z |
Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
|
Chiu N.-C.; LI-MIN HUANG; Willemsen A.; Bhusal C.; Arora A.K.; Reynoso Mojares Z.; Toneatto D. |
| 臺大學術典藏 |
2021-07-15T05:31:49Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu, Wang Da; Huang, Yu Shan; Lin, Yi Jiun; Hsieh, Erh Fang; Lian, Wei Cheng; Chen, Charles; Janssen, Robert; Shih, Shin Ru; Huang, Chung Guei; Tai, I. Chen; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-08-20T07:38:57Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; YU-SHAN HUANG; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-02T05:41:26Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; WANG-DA LIU; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T04:24:49Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2018-09-10T09:13:16Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang, Pan-Chyr;Yu, Chong-Jen;Chang, Shan-Chwen;Hsieh, Szu-Min;Drame, Mamadou;Walravens, Karl;Roman, Francois;Gillard, Paul; Yang, P.-C. and Yu, C.-J. and Chang, S.-C. and Hsieh, S.-M. and Drame, M. and Walravens, K. and Roman, F. and Gillard, P.; 張上淳 ;楊泮池 ;余忠仁 ;謝思民; Yang, Pan-Chyr; Chong-Jen Yu; Yu, Chong-Jen; SZU-MIN HSIEH; SHAN-CHWEN CHANG; Chang, Shan-Chwen; Hsieh, Szu-Min; Drame, Mamadou; Walravens, Karl; Roman, Francois; Gillard, Paul |
| 臺大學術典藏 |
2020-12-02T02:34:00Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
PAN-CHYR YANG; Yu C.-J.; Chang S.-C.; Hsieh S.-M.; Drame M.; Walravens K.; Roman F.; Gillard P. |
| 臺大學術典藏 |
2020-12-29T06:37:40Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Drame M.; Walravens K.; SZU-MIN HSIEH; Chang S.-C.; Yu C.-J.; Yang P.-C.; Roman F.; Gillard P. |
| 臺大學術典藏 |
2022-06-27T07:02:07Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang P.-C.; CHONG-JEN YU; Chang S.-C.; Hsieh S.-M.; Drame M.; Walravens K.; Roman F.; Gillard P. |
| 國立臺灣大學 |
2012 |
Safety and immunogenicity of a split-virion AS03(A)-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang, Pan-Chyr; Yu, Chong-Jen; Chang, Shan-Chwen; Hsieh, Szu-Min; Drame, Mamadou; Walravens, Karl; Roman, Francois; Gillard, Paul; 張上淳; 楊泮池; 余忠仁; 謝思民 |
| 國立臺灣大學 |
2011 |
Safety and Immunogenicity of a Tetravalent Meningococcal Serogroups a, C, W-135 and Y Conjugate Vaccine in Adolescents and Adults
|
黃立民; 林奏延; HUANG, LI-MIN; LIN, TZOU-YIEN |
| 臺大學術典藏 |
2021-06-24T07:16:54Z |
Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
|
Bermal N.; LI-MIN HUANG; Dubey A.P.; Jain H.; Bavdekar A.; Lin T.-Y.; Bianco V.; Baine Y.; Miller J.M. |
| 國立臺灣大學 |
2009 |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine against Meningococcal Disease
|
邵蓓嵐; 張鑾英; 謝思民; 張上淳; 盤松青; 呂俊毅; 謝育嘉; 李慶雲; 黃立民; SHAO, PEI-LAN; CHANG, LUAN-YIN; HSIEH, SZU-MIN; CHANG, SHAN-CHWEN; PAN, SUNG-CHING; LU, CHUN-YI; HSIEH, YU-CHIA; LEE, CHIN-YUN; HUANG, LI-MIN |
| 臺大學術典藏 |
2018-09-10T07:37:54Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Shao, PL;Chang, LY;Hsieh, SM;Chang, SC;Pan, SC;Lu, CY;Hsieh, YC;Lee, CY;Dobbelaere, K;Boutriau, D;Tang, H;Bock, HL;Huang, LM; Shao, P.-L. and Chang, L.-Y. and Hsieh, S.-M. and Chang, S.-C. and Pan, S.-C. and Lu, C.-Y. and Hsieh, Y.-C. and Lee, C.-Y. and Dobbelaere, K. and Boutriau, D. and Tang, H. and Bock, H.L. and Huang, L.-M.; Shao, PL; LUAN-YIN CHANG; SZU-MIN HSIEH; Chang, LY; Tang, H; Bock, HL; Huang, LM; Hsieh, SM; LI-MIN HUANG; Chang, SC; CHUN-YI LU; SHAN-CHWEN CHANG; Pan, SC; CHIN-YUN LEE; Lu, CY; Hsieh, YC; SUNG-CHING PAN; Lee, CY; Dobbelaere, K; Boutriau, D |
| 臺大學術典藏 |
2009 |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Lee C.-Y.; Hsieh Y.-C.; Chang L.-Y.; Hsieh S.-M.; Chang S.-C.; SUNG-CHING PAN; Lu C.-Y.; Shao P.-L.; Shao P.-L.;Chang L.-Y.;Hsieh S.-M.;Chang S.-C.;Sung-Ching Pan;Lu C.-Y.;Hsieh Y.-C.;Lee C.-Y.;Dobbelaere K.;Boutriau D.;Tang H.;Bock H.L.;Huang L.-M.; Dobbelaere K.; Boutriau D.; Tang H.; Bock H.L.; Huang L.-M. |
| 臺大學術典藏 |
2020-12-15T07:42:19Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Shao P.-L.; LUAN-YIN CHANG; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; Lu C.-Y.; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D.; Tang H.; Bock H.L.; Huang L.-M. |
| 臺大學術典藏 |
2009 |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Huang L.-M.; Tang H.; Bock H.L.; Boutriau D.; Dobbelaere K.; Lee C.-Y.; Hsieh Y.-C.; Lu C.-Y.; Pan S.-C.; Chang S.-C.; SZU-MIN HSIEH; Chang L.-Y.; Shao P.-L. |
| 臺大學術典藏 |
2021-01-08T02:16:23Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Chang L.-Y.; Shao P.-L.; Shao P.-L.;Chang L.-Y.;Hsieh S.-M.;Chang S.-C.;Pan S.-C.;Chun-Yi Lu;Hsieh Y.-C.;Lee C.-Y.;Dobbelaere K.;Boutriau D.;Tang H.;Bock H.L.;Huang L.-M.; Huang L.-M.; Bock H.L.; Tang H.; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; CHUN-YI LU; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D. |
| 臺大學術典藏 |
2021-05-06T08:26:14Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
PEI-LAN SHAO; Chang L.-Y.; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; Lu C.-Y.; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D.; Tang H.; Bock H.L.; Huang L.-M. |
| 臺大學術典藏 |
2021-06-24T07:17:01Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Shao P.-L.; Chang L.-Y.; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; Lu C.-Y.; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D.; Tang H.; Bock H.L.; LI-MIN HUANG |
| 國立臺灣大學 |
2009-06 |
Safety and immunogenicity of a tetravalent polysaccharide vaccine against meningococcal disease.
|
Shao, PL; Chang, LY; Hsieh, SM; Chang, SC; Pan, SC; Lu, CY; Hsieh, YC; Lee, CY; Dobbelaere, K; Boutriau, D; Tang, H; Bock, HL; Huang, LM |
| 臺大學術典藏 |
2020-09-29T01:47:35Z |
Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
|
Wu U.-I.; Hsieh S.-M.; Lee W.-S.; Wang N.-C.; Kung H.-C.; Ou T.-Y.; Chen F.-L.; Lin T.-Y.; YEE-CHUN CHEN; Chang S.-C. |